n.a. (ZMH)

Prev Close 0.00
Day Low/High 0.00 / 0.00
52 Wk Low/High 0.00 / 0.00
Exchange NYSE
Shares Outstanding 170.40M
Div & Yield N.A. (N.A)

Zimmer Taps Lawyer

Shares slip as some wonder about a government probe.

Cramer's 'Mad Money Lightning Round': Zesty Zimmer

What a quarter, Cramer says. He also is fond of Stryker.

Zimmer Zooms

Shares jump after a strong quarter.

Cramer's 'Mad Money Lightning Round': Medco Healthy

Cramer likes how it consistently trims pharmacy costs.

Cramer's 'Mad Money Lightning Round': Southern Copper Man

Cramer says the mining company is making money hand-over-fist.

Zimmer Looking Spry

The stock surges after hours.

Stryker Right on Target

Shares slip after a long run.

Zimmer Fans Fight Back

Spine surgeons question the findings of a disc study.

Zimmer Gets a Leg Up

Artificial joint makers flex their muscles after an upgrade.

Device Makers Look to Evolve

The space could see some big mergers in the coming year.

Zimmer Offers Mixed Guidance

It's light in the first quarter but solid for 2007.

Biomet Gets a Boost

But some shudder at antitrust implications.

New Twist at Zimmer

Longtime CEO Ray Elliott plans to step down.

Smith & Nephew Fans Cry Uncle

Shares slip on talk of a merger with overseas rival Biomet.

Sales View Gets Dimmer at Zimmer

Sales View Gets Dimmer at Zimmer

Shares slip after the top line falls short a third straight time.

Cramer's 'Mad Money Lightning Round': Mirant No Mirage

Cramer's 'Mad Money Lightning Round': Mirant No Mirage

Cramer says it's worth a lot more than what it's selling for.

Cramer's 'Mad Money Lightning Round': Boston Baked

Cramer's 'Mad Money Lightning Round': Boston Baked

Cramer says Boston Scientific paid too much for Guidant.

Biomet Catches a Break

Orthopedic stocks rally on a pricing decision.

Zimmer Zigs and Zags

Investors warm up to joint replacement stocks after a long selloff.

Zimmer Takes a Knee

After hours, the stock gives back much of Wednesday's gains.

Slowdown Fears Elbow Biomet

Slowdown Fears Elbow Biomet

A government probe needles the artificial-joint players.

Friday's Health Winners & Losers

Friday's Health Winners & Losers

Sepracor falls, but Zimmer is up.

Betting on Boomers for a Healthy Investment

Betting on Boomers for a Healthy Investment

With health stocks at such low prices, now is the time to bet on the needs of the aging generation.

Zimmer Gets Subpoena

Zimmer Gets Subpoena

The company says a criminal probe includes antitrust allegations.

Suits Target J&J Discs

Lawyers claim Johnson & Johnson's artificial disks are prone to painful failures.

J&J Hip Attracts Anxiety

The company's new metal implant is supposed to last longer, but safety concerns linger.

Zimmer Knee's Feminine Twist

The company says its new implant fits women better. But some see mere marketing hype.

The Real Story: Encore Medical Primed for 2007

The stock's discount should diminish as it works through recent acquisitions.

Get Connected to MRV's Success

The conference call spells out exactly how much is going right for this company.

Zimmer Fans on Edge

The latest sales shortfall raises some eyebrows on Wall Street.